The frequency of HLA-I deficiency (≥1% tumor cells) is significantly higher in MSI tumors (52%) compared with EBV-positive tumors (23%) and the other tumors (28%), while the PD-L1 expression level is higher in EBV-positive tumors, followed by MSI tumors. This evidence concerns the gene CD274 and neoplasm.